Karyopherin-mediated nucleocytoplasmic transport

CE Wing, HYJ Fung, YM Chook - Nature reviews Molecular cell biology, 2022 - nature.com
Efficient and regulated nucleocytoplasmic trafficking of macromolecules to the correct
subcellular compartment is critical for proper functions of the eukaryotic cell. The majority of …

The nuclear export protein XPO1—from biology to targeted therapy

AS Azmi, MH Uddin, RM Mohammad - Nature reviews Clinical oncology, 2021 - nature.com
Abstract Exportin 1 (XPO1), also known as chromosome region maintenance protein 1,
plays a crucial role in maintaining cellular homeostasis via the regulated export of a range of …

Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy

JL Carter, K Hege, J Yang, HA Kalpage, Y Su… - Signal transduction and …, 2020 - nature.com
Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults and the
second most common form of acute leukemia in children. Despite this, very little …

Genomic and molecular characterization of esophageal squamous cell carcinoma

DC Lin, JJ Hao, Y Nagata, L Xu, L Shang, X Meng… - Nature …, 2014 - nature.com
Esophageal squamous cell carcinoma (ESCC) is prevalent worldwide and particularly
common in certain regions of Asia. Here we report the whole-exome or targeted deep …

Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma

E Tiacci, E Ladewig, G Schiavoni… - Blood, The Journal …, 2018 - ashpublications.org
Dissecting the pathogenesis of classical Hodgkin lymphoma (cHL), a common cancer in
young adults, remains challenging because of the rarity of tumor cells in involved tissues …

Nucleo-cytoplasmic transport as a therapeutic target of cancer

GL Gravina, W Senapedis, D McCauley… - Journal of hematology & …, 2014 - Springer
Shuttling of specific proteins out of the nucleus is essential for the regulation of the cell cycle
and proliferation of both normal and malignant tissues. Dysregulation of this fundamental …

First-in-class, first-in-human phase I study of selinexor, a selective inhibitor of nuclear export, in patients with advanced solid tumors

AR Abdul Razak, M Mau-Soerensen… - Journal of Clinical …, 2016 - ascopubs.org
Purpose This trial evaluated the safety, pharmacokinetics, pharmacodynamics, and efficacy
of selinexor (KPT-330), a novel, oral small-molecule inhibitor of exportin 1 (XPO1/CRM1) …

Next-generation sequencing in diffuse large B-cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA study

S Dubois, PJ Viailly, S Mareschal, E Bohers… - Clinical cancer …, 2016 - AACR
Purpose: Next-generation sequencing (NGS) has detailed the genomic characterization of
diffuse large B-cell lymphoma (DLBCL) by identifying recurrent somatic mutations. We set …

CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications

YT Tai, Y Landesman, C Acharya, Y Calle, MY Zhong… - Leukemia, 2014 - nature.com
The key nuclear export protein CRM1/XPO1 may represent a promising novel therapeutic
target in human multiple myeloma (MM). Here we showed that chromosome region …

XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer

J Kim, E McMillan, HS Kim, N Venkateswaran… - Nature, 2016 - nature.com
The common participation of oncogenic KRAS proteins in many of the most lethal human
cancers, together with the ease of detecting somatic KRAS mutant alleles in patient samples …